Do you want to read an article? Please log in or register.
Improvements in frailty contribute to substantial improvements in quality of life after lung transplantation in patients with cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Transplantation experience as a predictor for quality of life during the first 6 months after lung transplantation
Clin Transplant.
Goetzmann L, Seiler A, Benden C, Boehler A, Büchi S, Jenewein J, Ruettner B, Mueller-Alcazar A, Weierstall R
doi: 10.1111/ctr.13393.
Pulmonary Fibrosis
Tracheal diverticula in advanced cystic fibrosis: Prevalence, features, and outcomes after lung transplantation
J Cyst Fibros.
Kapnadak SG, Kicska GA, Ramos KJ, Marshall DA, Carroll TY, Pipavath SN, Mulligan MS, Goss CH, Aitken ML
doi: 10.1016/j.jcf.2017.07.015.
RECOMMENDED
Further Publications
Health-related quality of life and stress-related post-transplant trajectories of lung transplant recipients: a three-year follow-up of the Swiss Transplant Cohort Study
Swiss Med Wkly.
Bleisch B, Schuurmans MM, Klaghofer R, Benden C, Seiler A, Jenewein J
doi: 10.4414/smw.
RECOMMENDED
Pulmonary Fibrosis
The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Havermans T, Houben J, Vermeulen F, Boon M, Proesmans M, Lorent N, de Soir E, Vos R, Dupont L
doi: 10.1016/j.jcf.2020.07.022.
Pulmonary Fibrosis
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment
J Cyst Fibros.
Nagy B Jr, Bene Z, Fejes Z, Heltshe SL, Reid D, Ronan NJ, McCarthy Y, Smith D, Nagy A, Joseloff E, Balla G, Kappelmayer J, Macek M Jr, Bell SC, Plant BJ, Amaral MD, Balogh I
doi: 10.1016/j.jcf.2018.08.013.
COMMENTED
Pulmonary Fibrosis
Lung transplantation for cystic fibrosis
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
doi: 10.1016/j.healun.2020.02.010.
RECOMMENDED
Bronchi
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials
Lancet Respir Med.
Haworth CS, Bilton D, Chalmers JD, Davis AM, Froehlich J, Gonda I, Thompson B, Wanner A, O'Donnell AE
doi: 10.1016/S2213-2600(18)30427-2.
RECOMMENDED
Pulmonary FibrosisRespiratory Tract InfectionFurther Publications
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial
Lancet Respir Med.
Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA
doi: 10.1016/
RECOMMENDED
Pulmonary Fibrosis
Predictors of long-term employment among patients with cystic fibrosis undergoing lung transplantation
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Swiss Med Wkly.
Radtke T, Königs A, Chen X, Braun J, Dressel H, Benden C
doi: 10.4414/smw.2020.20286.